BSA204

· Bisirna Therapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BSA204, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) [Phase 1]